HUE048496T2 - Kroszpovidont tartalmazó tabletta - Google Patents

Kroszpovidont tartalmazó tabletta

Info

Publication number
HUE048496T2
HUE048496T2 HUE14766730A HUE14766730A HUE048496T2 HU E048496 T2 HUE048496 T2 HU E048496T2 HU E14766730 A HUE14766730 A HU E14766730A HU E14766730 A HUE14766730 A HU E14766730A HU E048496 T2 HUE048496 T2 HU E048496T2
Authority
HU
Hungary
Prior art keywords
crospovidone
tablet
Prior art date
Application number
HUE14766730A
Other languages
English (en)
Inventor
Abraham Cornelis Lardee
Original Assignee
Centrient Pharmaceuticals Netherlands B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centrient Pharmaceuticals Netherlands B V filed Critical Centrient Pharmaceuticals Netherlands B V
Publication of HUE048496T2 publication Critical patent/HUE048496T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/424Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE14766730A 2013-09-20 2014-09-18 Kroszpovidont tartalmazó tabletta HUE048496T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13185368 2013-09-20

Publications (1)

Publication Number Publication Date
HUE048496T2 true HUE048496T2 (hu) 2020-07-28

Family

ID=49223642

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14766730A HUE048496T2 (hu) 2013-09-20 2014-09-18 Kroszpovidont tartalmazó tabletta

Country Status (11)

Country Link
US (1) US10159647B2 (hu)
EP (1) EP3046548B1 (hu)
CN (1) CN105555261B (hu)
DK (1) DK3046548T3 (hu)
ES (1) ES2780874T3 (hu)
HU (1) HUE048496T2 (hu)
PL (1) PL3046548T3 (hu)
PT (1) PT3046548T (hu)
RS (1) RS60054B1 (hu)
SI (1) SI3046548T1 (hu)
WO (1) WO2015040093A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
WO2022017864A1 (en) * 2020-07-24 2022-01-27 Dsm Ip Assets B.V. New fast dissolvable tablets
CN113274357B (zh) * 2021-05-28 2022-12-27 广州白云山医药集团股份有限公司白云山制药总厂 一种阿莫西林药物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9200139A (en) 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
CN1194687C (zh) * 1997-02-14 2005-03-30 史密斯克莱恩比彻姆药物实验室 含有阿莫西林和克拉维酸盐的药物制剂
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
US6878386B1 (en) * 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US20020006433A1 (en) 1999-04-29 2002-01-17 Nigel P. Davidson Pharmaceutical formulations

Also Published As

Publication number Publication date
CN105555261B (zh) 2020-02-11
SI3046548T1 (sl) 2020-04-30
PT3046548T (pt) 2020-03-04
US20160193153A1 (en) 2016-07-07
CN105555261A (zh) 2016-05-04
EP3046548A1 (en) 2016-07-27
ES2780874T3 (es) 2020-08-27
EP3046548B1 (en) 2020-02-12
RS60054B1 (sr) 2020-04-30
PL3046548T3 (pl) 2020-07-13
DK3046548T3 (da) 2020-04-27
WO2015040093A1 (en) 2015-03-26
US10159647B2 (en) 2018-12-25

Similar Documents

Publication Publication Date Title
HK1219663A1 (zh) 藥物組合
GB201306312D0 (en) Tablet case
HRP20180684T1 (hr) Kombinacija lijekova
GB201322602D0 (en) Pharmaceutical compounds
GB201302901D0 (en) Ubuntu tablet
GB201306610D0 (en) Pharmaceutical compounds
ZA201602047B (en) Pharmaceutical compounds
IL241350A0 (en) Subprevir tablets
HK1205463A1 (zh) 含有 -羥基- -咪唑- -甲酰胺的片劑
GB201312386D0 (en) Pharmaceutical compounds
PL3046548T3 (pl) Tabletka zawierająca krospowidon
EP3069714A4 (en) Tablet
GB201316662D0 (en) Pharmaceutical Combination
GB201317166D0 (en) Pharmaceutical compounds
GB201316780D0 (en) Pharmaceutical compounds
GB201316791D0 (en) Pharmaceutical Compounds
GB201315733D0 (en) Pharmaceutical compounds
GB201315734D0 (en) Pharmaceutical compounds
GB201312464D0 (en) Pharmaceutical compounds
GB201308780D0 (en) Pharmaceutical compounds
GB201308781D0 (en) Pharmaceutical compounds
GB201308782D0 (en) Pharmaceutical compounds
GB201310496D0 (en) Pharmaceutical combinations
GB201301723D0 (en) Pharmaceutical combinations